Clinical Trial Update: JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme [Phase 3]

View source ↗

Summary

Phase 3 trial in Japan comparing Aggrenox to aspirin for stroke prevention completed; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Aggrenox (aspirin and dipyridamole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cerebrovascular Accident | Phase 3 | Status: COMPLETED | Results posted: 2010-03-11